NDC 62032-0106-10
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 62032-0106-10
- Product root
- 62032-0106
- Identity scope
- Package
- Primary current NDC product row
- Not present
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 62032-106 | 62032-106-10 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 62032-106 | 62032-106-10 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 62032-106 | 62032-106-10 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Obagi-C C-Rx System Normal-Dry Skin Intervention | HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE | Obagi Cosmeceuticals LLC | ca931d1c-4df4-47ce-8d5c-cd8c3e38c02b | 2026-01-26 | Warnings | 62032010610 |
| Obagi-C C-Rx System Normal-Dry Skin Intervention | HYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE | Obagi Cosmeceuticals LLC | e9d8488f-b902-45f4-a6d6-c6eb393c8f08 | 2025-11-13 | Warnings | 62032010610 |
| OBAGI C RX system C CLARIFYING SERUM | HYDROQUINONE | Obagi Cosmeceuticals LLC | 9ff4f617-b8d3-46d6-8ddb-41088dd8f226 | 2025-01-01 | Warnings, Adverse reactions | 62032010610 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.